RESUMEN

A pesar de los avances tecnológicos para el diagnóstico de la hipertensión pulmonar, la historia clínica y la exploración física aún se consideran fundamentales como método de escrutinio siempre y cuando se dominen los aspectos teóricos, sus fundamentos y sus limitaciones. Con la identificación de los factores de riesgo, la exclusión de aquellas entidades que forman parte del diagnóstico diferencial, una adecuada auscultación y el análisis del conjunto de variables clínicas obtenidas, se provee de importantes pistas que pudieran auxiliar en la detección lo más oportunamente posible de la enfermedad o contribuir en el seguimiento de estos pacientes.

PALABRAS CLAVE

Hipertensión pulmonar, exploración física, insuficiencia cardíaca derecha, ventrículo derecho.

REFERENCIAS

1. Peacock AJ. The diagnosis of pulmonary hypertension. Clinical features. In: Peacock AJ, Rubin LJ, editors. Pulmonary circulation. Diseases and their treatment. 2a ed. New York: Arnold publishers; 2004.p.73.

2. Galiè N, McLaughlin VV, Rubin LJ, Simonneau G. An overview of the 6th World Symposium on Pulmonary Hypertension. Eur Respir J 2019;53(1).pii1802148. https://doi.org/10.1183/13993003.02148-2018.

3. Guadalajara-Boo JF. La auscultación del corazón, un arte en vías de extinción. Gac Med Mex 2015;151(2):260-265.

4. Patil S, Henry JW, Rubenfire M, Stein PD. Neural network in the clinical diagnosis of acute pulmonary embolism. Chest 1993;104(6):1685-1689. https://doi.org/10.1378/chest.104.6.1685.

5. Freeman LM, Krynyckyi B, Zuckier LS. Enhanced lung scan diagnosis of pulmonary embolism with the use of ancillary scintigraphicfinfdings and clinical correlation. Semin Nucl Med 2001;31(2):143-157.

6. Colman R, Whittingham H, Tomlinson G, Granton J. Utility of the physical examination in detecting pulmonary hypertension. A mixed methods study. PLoSOne 2014;9(10):e108499. https://doi.org/10.1371/journal.pone.0108499.

7. Marcus GM, Vessey J, Jordan MV, et al. Relationship between accurate auscultation of a clinically useful third heart sound and level of experience. Arch Intern Med 2006;166(6):617-622. https://doi.org/10.1001/archinte.166.6.617.

8. Flores-Franco RA. La auscultación como metodología diagnóstica. En: Flores-Franco RA, Gómez-Sáenz LM, editores. La estetoscopia. Teoría, práctica y enseñanza-aprendizaje. México: Trillas; 2018.p.29.

9. Granton JT, Whittingham H, Tomlinson G, et al. Does this patient have pulmonary hypertension? A prospective evaluation of the utility of the physical examination. Am J Respir Crit Care Med 2010;181:A3372. https://doi.org/10.1164/ajrccm-conference.2010.181.1_MeetingAbstracts.A3372-

10. Fraser AG, Weston CF. The Graham Steell murmur: eponymous serendipity? J R Coll Physicians Lond 1991;25(1):66-70.

11. Hui-Li G. The management of acute pulmonary arterial hypertension. CardiovascTher 2011;29(3):153-175. https://doi.org/10.1111/j.1755-5922.2009.00095.x.

12. Wells PS, Anderson DR, Rodger M, et al. Derivation of a simple clinical model to categorize patients probability of pulmonary embolism: Increasing the models utility with the SimpliRED D-dimer. Thromb Haemost 2000;83(3):416-420.

13. Stein PD. Relation of right-sided pressures to clinical characteristics of patients with no prior cardiopulmonary disease. In: Stein PD, editor. Pulmonary embolism. 3rd ed. Oxford, UK: Wiley Blackwell; 2016.p. 272-274.

14. Stein PD, Beemath A, Matta F, et al. Clinical characteristics of patients with acute pulmonary embolism: data from PIOPED II. Am J Med 2007;120(10):871-879.

15. Light RW. Pleural effusion due to pulmonary emboli. CurrOpinPulm Med2001;7(4):198-201.

16. Stein PD. Clinical characteristics of patients with acute pulmonary embolism stratified according to their presenting syndromes. In: Stein PD, editor.Pulmonary embolism. 3rd ed. Oxford, UK: Wiley Blackwell; 2016.p. 280-285.

17. Riedel M. Diagnosing pulmonary embolism. Postgrad Med J 2004;80(944):309-319.

18. Lobo-Beristáin JL, Egea-Santaolalla C. Síndromes clínicos de embolia pulmonar. Semin Fund Esp Reumatol 2006;7(3):139-146. doi: 10.1016/S1577-3566(06)75092-8.

19. Hughes MJ, Stein PD, Matta F. Silent pulmonary embolism in patients with distal deep venous thrombosis: systemic review. Thromb Res 2014;134(6):1182-1185. https://doi.org/10.1016/j.thromres.2014.09.036.

20. Hill NS. The cardiac exam in lung disease. Clin Chest Med 1987;8(2):273-285.

21. Don Michael TA. Eliciting heart sounds: timing, amplitude, and pitch. In: Don Michel TA, editor. Auscultation of the heart. A cardiophonetic approach. New York, USA: McGraw-Hill; 1998.p.113-160.

22. Mauritz GJ, Marcus JT, Westerhof N, Postmus PE, Vonk-Noordegraaf A. Prolonged right ventricular post-systolic isovolumic period in pulmonary arterial hypertension is not a reflection of diastolic dysfunction. Heart 2011;97(6):473-478. https://doi.org/10.1136/hrt.2010.193375.

23. Fraser RS, Lynne-Davies P. Continuous chest murmur acquired following pulmonary thromboembolism. Chest 1974;65:562-564.

24. ZuWallack RL, Liss JP, Lahiri B. Acquired continuous murmur associated with acute pulmonary thromboembolism. Chest 1976;70(4):557-559. https://doi.org/10.1378/chest.70.4.557.

25. Santos-Martínez LE. Fisiopatología de la falla ventricular derecha en la hipertensión arterial pulmonar. Arch Cardiol Mex 2004;74(Supl 2):S353-S357.

26. Renshaw SA, SR Brennan, Heigenbottam TW. The clinical presentation of deep vein thrombosis and pulmonary thromboembolism. In: Oudkerk M, van Beek EJR, ten Cate JW, editors. Pulmonary embolism. Oxford, UK: Blackwell Science; 1999.p.34-42.

27. Shank-Coviello J. Fundamentos de los soplos. En Shank-Coviello J, editor. Manual interactivo de auscultacióncardíaca y respiratoria. 5a ed. Philadelphia, PA: Wolters Kluwer/Lippincott Williams & Wilkins; 2016.p.56-78.

28. Stein PD, Matta F, Musani MH, Diaczok B. Silent pulmonary embolism in patients with deep venous thrombosis: a systemic review. Am J Med 2010;123(5):426-431. https://doi.org/10.1016/j.amjmed.2009.09.037.

29. Sharma GV, Sasahara AA. Diagnosis and treatment of pulmonary embolism. Med Clin North Am 1979;63(1):239-250.

30. Manganelli D, Palla A, Donnamaria V, Giuntini C.Clinical features of pulmonary embolism. Doubts and certainties. Chest 1995;107(1 Suppl):25S-32S. https://doi.org/10.1378/chest.107.1_supplement.25s.

31. Simonneau G, Galiè N, Rubin L, et al. Clinical classification of pulmonary hypertension. J Am Coll Cardiol 2004;43(12 Suppl):S5-S12.

32. Maron BA, Choudhary G, Kahn UA, et al. The clinical profile and underdiagnosis of pulmonary hypertension in US veteran patients. CircHeart Fail 2013;6(5):906-912. https://doi.org/10.1161/CIRCHEARTFAILURE.112.000091.

33. Deaño RC, Glassner-Kolmin C, Rubenfire M, et al. Referral of patients with pulmonary hypertension diagnoses to tertiary pulmonary hypertension centers: the multicenter RePHerral study. JAMA Intern Med 2013;173(10):887-893. https://doi.org/10.1001/jamainternmed.2013.319.

34. Humbert M. Pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: pathophysiology. Eur Respir Rev 2010;19(115): 59-63. https://doi.org/10.1183/09059180.00007309.

35. Lai YC, Potoka KC, Champion HC, Mora AL, Gladwin MT. Pulmonary arterial hypertension: the clinical syndrome.Circ Res 2014;115(1):115-130. https://doi.org/10.1161/CIRCRESAHA.115.301146.

36. Matura LA, Shou H, Fritz JS, et al. Physical activity and symptoms in pulmonary arterial hypertension. Chest 2016;150(1):46-56.https://doi.org/10.1016/j.chest.2016.02.633

37. Delcroix M, Howard L. Pulmonary arterial hypertension: the burden of disease and impact on quality of life. Eur Respir Rev 2015;24:621-629.

38. Dumitrescu D, Sitbon O, Weatherald J, Howard LS. Exertional dyspnoea in pulmonary arterial hypertension. Eur Respir Rev 2017;26(145).pii:170039. https://doi.org/10.1183/16000617.0039-2017.

39. Sun PY, Jiang X, Gomberg-Maitland M, et al. Prolonged QRS duration: a new predictor of adverse outcome in idiopathic pulmonary arterial hypertension. Chest 2012;141(2):374-380. https://doi.org/10.1378/chest.10-3331.

40. Leier CV,Young JB, Levine TB, et al. Nuggets, pearls, and vignettes of master heart failure clinicians. Part 2-the physical examination. Congest Heart Fail 2001;7(6):297-308.

41. Mcnab P, Castro P, Verdejo H, Martínez G. Estimación auscultatoria de la presión sistólica de arteria pulmonar: ¿Es factible? Correlación con determinación ecocardiográfica. Rev Med Chile 2010;138(11):1351-1356.

42. Brunk SF. Auscultatory percussion: an added dimension in physical diagnosis. Int J Clin Pract 2003;57(3):209-209.

43. Caplin M, Moshier AL. Abnormal heart sounds: other diastolic and systolic sounds.In: Caplin M, Moshier AL, editors. Auscultation Sskills.Breath & heart sounds. 3ra ed. Ambler, PA:Williams& Wilkins; 2006.p.53.

44. Gómez-Sáenz LM. Auscultación cardíaca. En Flores-Franco RA, Gómez-Sáenz LM, editor. La estetoscopia. Teoría, práctica y enseñanza-aprendizaje. México: Trillas; 2018.p.80.

45. Mandel J. Approach to the patient with pulmonary hypertension. In: Mandel T, editor. Pulmonary vascular disease. Philadelphia, PA: Saunders Elsevier; 2006.p.84-85.

46. Sandoval-Zárate J. Right ventricle insufficiency in pulmonary arterial hypertension. Physiopathologic considerations. Arch Cardiol Mex 2001;71 Suppl1:S164-S167.

47. Bhattacharya A. Cor pulmonale. JIACM 2004;5(2):128-136.

48. Diller GD, Gatzoulis MA. Pulmonary vascular disease in adults with congenital heart disease. Circulation 2007;115(8):1039-1050. https://doi.org/10.1161/CIRCULATIONAHA.105.592386.